Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 9, 2011, Pages 1068-1073

  Gatta, D ^a   Aliprandi, G ^b   Pini, L ^a   Zanardini, A ^b   Fredi, M ^b   Tantucci, Claudio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Hospice Domus Salutis   (Italy)

Author keywords

C reactive protein; COPD; Dynamic hyperinflation; Inspiratory capacity

Indexed keywords

ALBUMIN; ALPHA 1 GLOBULIN; C REACTIVE PROTEIN; GLOBULIN; UNCLASSIFIED DRUG; URIC ACID;

AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYNAMIC PULMONARY HYPERINFLATION; FEMALE; HUMAN; HYPERINFLATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSPIRATORY CAPACITY; ITALY; LEUKOCYTE COUNT; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; URIC ACID;

EID: 80054874700     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. NOGUERA A, BUSQUETS X, SAULEDA J, VILLAVERDE JM, MACNEE W, AGUSTI AG. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1664-1668.
2. SAULEDA J, GARCIA-PALMER FJ, GONZALES G, PALOU A, AGUSTI AG. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis. Am J Respir Crit Care Med 2000; 161: 32-35.
3. GAN WQ, MAN SFP, SENTHILSELVAN A, SIN DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
4. MAN SFP, CONNETT JE, ANTHONISEN NR, WISE RA, TASHKIN DP, SIN DD. C-reactive protein and mortality in mild-to-moderate chronic obstructive pulmonary disease. Thorax 2006; 61: 849-853.
5. DAHL M, VESTBO J, LANGE P, BOJESEN SE, TYBJAERG-HANSEN A, NORDESTGAARD BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2007; 175: 250-255.
6. SIN DD, MAN SFP. Systemic inflammation and mortality in chronic obstructive pulmonary disease Can J Physiol Pharmacol 2007; 85: 141-147.
7. DE MARTINIS M, FRANCESCHI C, MONTI D, GINALDI L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Letters 2005; 579: 2035-2039.
8. CELERMAJER DS, ADAMS MR, CLARKSON P, ROBINSON J, MCCREDIE R, DONALD A, DEANFIELD JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-154.
9. MORLA M, BUSOUETS X, PONS J, SAULEDA J, MACNEE W, AGUSTI AG. Telomere shortening in smokers with and without COPD. Eur Respir J 2006; 27: 525-528.
10. VASSILAKOPOULOS T, KATSAOUNOU P, KARATZA MH, KOLLINTZA A, ZAKYNTHINOS S, ROUSSOS C. Strenuous resistive breathing induces plasma cytokines: role of antioxidants and monocytes. Am J Respir Crit Care Med 2002; 166: 1572-1578.
11. CASADEVALL C, CORNELL C, RAMIREZ-SARMIENTO AL, MARTÍNEZ-LLORENS J, BARREIRO E, OROZCO-LEVI M, GEA J. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J 2007; 30: 701-707.
12. AGUSTI A, MACNEE W, DONALDSON K, COSIO M. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58: 832-834.
13. RABINOVICH RA, FIGUERAS M, ARDITE E, CARBÓ N, TROOSTERS T, FILELLA X, BARBERÀ JA, FERNANDEZ-CHECA JC, ARGILÉS JM, ROCA J. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 2003; 21: 789-794.
14. TANTUCCI C, DUGUET A, SIMILOWSKI T, ZELTER M, DERENNE JP, MILIC-EMILI J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
15. TANTUCCI C, DONATI P, NICOSIAF,R BERTELLA E, REDOLFI S, DE VECCHI M, CORDA L, GRASSI V, ZULU R. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Resp Med 2008; 102: 613-619.
16. DIAZ O, VILLAFRANCA C, GHEZZO H, BORZONE G, LEIVA A MILIC-EMIL J, LISBOA C. Role of inspiratory capacity on exercise tolerance in COPD patients with and without expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-275.
17. ZULLI R, DONATI P, NICOSIA F, DE VECCHI M, TANTUCCI C, ROMANELLI G, GRASSI V. Increased QT dispersion: a negative prognostic finding in chronic obstructive pulmonary disease. Intern Emerg Med 2006; 1: 279-286.
18. NOVALI M, LA PIANA GE, TARANTO-MONTEMUSSO L, et al. Predictive factors of sleep oxygen desaturation in COPD patients without daytime respiratory failure and OSAH. Am J Respir Crit Care Med 2008; A935.
19. AGUSTI A, SORIANO JB. Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship? Eur Respir J 2006; 100: 68-71.
20. CHARLSON ME, POMPEI P, ALES KL, MACKENZIE CR. New method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383.
21. TANTUCCI C, PINELU V, COSSI S, GUERINI M, DONATO F, GRASSI V. The SARA study group. Reference values and repeatability of inspiratory capacity for men and women aged 65-85. Resp Med 2006; 100: 871-877.
22. SOLER-CATALUNA JJ, MARTINEZ-GARCIA MA, ROMÁN SANCHEZ P, SALCEDO E, NAVARRO M, OCHANDO R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931.
23. O'DONNELL DE. Hyperinflation, dyspnea and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 180-184.
24. VASSAUX C, TORRE-BOUSCOULET L, ZEINEIDINE S, CORTOPASSI F, PAZ-DIAZ H, CELLI BR, PINTO-PLATA VM. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32: 1275-1282.
25. MYERS J, PRAKASH M, FROELICHER V, DO D, PARTINGTON S, ATWOOD JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793-801.
26. OGA T, NISHIMURA K, TSUKINO M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-549.
27. PINTO-PLATA VM, COTE C, CABRAL H, TAYLOR J, CELLI BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33.
28. VLAHAKIS NE, SCHROEDER MA, LIMPER AH, HUBMAYR RD. Stretch induces cytokine release by alveolar epithelial cells in vitro. Am J Physiol 1999; 277: L167-L173.
29. RANIERI MV, SUTER PM, TORTORELLA C, DE TULLIO R, DAYER JM, BRIENZA A, BRUNO F, SLUTSKY AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999; 282: 54-61.
30. SHI Y, EVANS JE, ROCK KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.